Drug Studies 2003-2004The Research Institute at Pepin Heart Hospital is proud to participate in a variety of drug studies, which allow us to introduce lifesaving pharmaceutical breakthroughs long before they are available at most other hospitals.
study
sponsor
monitor
status
number enrolled
ACUITY
Acute Coronary Syndrome
The Medicine Company
International Health Care
Ongoing
2
CRUSADE
ACS Registry
Millenium
Duke Clinical Research Institute
210
EASE
Lipid Study
Merck
Completed
EXPEDITION
CABG Study
Aventist
Quintiles
74
LUNAR
Cholesterol Study
Astra Zeneca
ICON
7
NEUTRALASE
Biomarin
Closed by Sponsor
1
PARA 0505-071
CABG Pain Study
Pharmacid
Pfizer
4
PRIMO
Alexion
40
PROVE IT (TIMI 22)
Bristol-Meyers Squibb
Timi Group
18
REPLACE
Angiomax Study
Cleveland Clinic
11
SOLVAY
Post-CABG Study
Solvay Pharmaceuticals
SYNERGY
Enoxaparin Study